US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 18.030
  • +0.210+1.18%
Close Nov 4 16:00 ET
  • 18.030
  • 0.0000.00%
Post 16:02 ET
1.62BMarket Cap-6881P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-84.20%-53.98M
-71.36%-54.6M
-1,424.13%-141.22M
-29.31M
-31.86M
136.14%10.67M
-301.92%-29.51M
-7.34M
Net income from continuing operations
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
---38.29M
---42.02M
45.83%-22.63M
-490.94%-41.79M
---7.07M
Operating gains losses
-2,161.14%-8.7M
1,231.02%41.37M
-51.56%5.23M
--422K
--3.11M
1,410.81%10.79M
-2,688.05%-823K
---29.52K
Depreciation and amortization
46.15%19K
66.67%15K
444.44%49K
--13K
--9K
80.00%9K
306.52%5K
--1.23K
Other non cash items
100.00%2K
-50.00%1K
-99.93%6K
--1K
--2K
8.61%8.01M
1,717.51%7.38M
--405.88K
Change In working capital
-587.47%-14.59M
-1,647.76%-10.14M
-43.45%5.87M
--2.99M
---580K
132.06%10.37M
788.31%4.47M
---649.41K
-Change in prepaid assets
-269.36%-9.23M
167.66%956K
196.32%4.03M
--5.45M
---1.41M
20.01%-4.19M
-213.47%-5.23M
---1.67M
-Change in payables and accrued expense
-314.29%-3.07M
-337.72%-9.69M
372.35%10.54M
---742K
--4.08M
-139.89%-3.87M
851.52%9.7M
--1.02M
-Change in other working capital
-32.73%-2.28M
56.81%-1.4M
-147.24%-8.71M
---1.72M
---3.24M
--18.43M
----
----
Cash from discontinued investing activities
Operating cash flow
-84.20%-53.98M
-71.36%-54.6M
-1,424.13%-141.22M
---29.31M
---31.86M
136.14%10.67M
-301.92%-29.51M
---7.34M
Investing cash flow
Cash flow from continuing investing activities
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
-5K
-7K
-820.83%-221K
-50.10%-24K
-15.99K
Net PPE purchase and sale
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
---5K
---7K
-820.83%-221K
-50.10%-24K
---15.99K
Cash from discontinued investing activities
Investing cash flow
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
---5K
---7K
-820.83%-221K
-50.10%-24K
---15.99K
Financing cash flow
Cash flow from continuing financing activities
-26.46%4.66M
8,185.12%198.18M
-97.73%8.91M
6.33M
2.39M
362.68%391.91M
508.37%84.7M
13.92M
Net issuance payments of debt
----
----
--0
----
----
--747K
--0
--13.92M
Net common stock issuance
--0
--190.48M
--0
--0
--0
368.63%396.95M
--84.7M
--0
Proceeds from stock option exercised by employees
-26.46%4.66M
284.74%9.2M
--8.91M
--6.33M
--2.39M
--0
--0
----
Net other financing activities
--0
---1.5M
----
----
----
---5.79M
----
----
Cash from discontinued financing activities
Financing cash flow
-26.46%4.66M
8,185.12%198.18M
-97.73%8.91M
--6.33M
--2.39M
362.68%391.91M
508.37%84.7M
--13.92M
Net cash flow
Beginning cash position
9.03%481.15M
-27.21%340.45M
677.85%467.73M
--441.31M
--467.73M
523.38%60.13M
213.70%9.65M
--3.07M
Current changes in cash
-115.57%-49.53M
585.76%143.19M
-132.89%-132.33M
---22.98M
---29.48M
629.32%402.35M
740.43%55.17M
--6.56M
Effect of exchange rate changes
44.23%-909K
-181.52%-2.5M
-3.73%5.05M
---1.63M
--3.06M
212.06%5.25M
-15,964.44%-4.68M
--29.52K
End cash Position
3.36%430.71M
9.03%481.15M
-27.21%340.45M
--416.71M
--441.31M
677.85%467.73M
521.92%60.13M
--9.67M
Free cash flow
-84.88%-54.19M
-72.54%-54.99M
-1,452.37%-141.24M
---29.31M
---31.87M
135.36%10.44M
-301.37%-29.54M
---7.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -84.20%-53.98M-71.36%-54.6M-1,424.13%-141.22M-29.31M-31.86M136.14%10.67M-301.92%-29.51M-7.34M
Net income from continuing operations -1.87%-39.01M-123.16%-93.77M-681.73%-176.94M---38.29M---42.02M45.83%-22.63M-490.94%-41.79M---7.07M
Operating gains losses -2,161.14%-8.7M1,231.02%41.37M-51.56%5.23M--422K--3.11M1,410.81%10.79M-2,688.05%-823K---29.52K
Depreciation and amortization 46.15%19K66.67%15K444.44%49K--13K--9K80.00%9K306.52%5K--1.23K
Other non cash items 100.00%2K-50.00%1K-99.93%6K--1K--2K8.61%8.01M1,717.51%7.38M--405.88K
Change In working capital -587.47%-14.59M-1,647.76%-10.14M-43.45%5.87M--2.99M---580K132.06%10.37M788.31%4.47M---649.41K
-Change in prepaid assets -269.36%-9.23M167.66%956K196.32%4.03M--5.45M---1.41M20.01%-4.19M-213.47%-5.23M---1.67M
-Change in payables and accrued expense -314.29%-3.07M-337.72%-9.69M372.35%10.54M---742K--4.08M-139.89%-3.87M851.52%9.7M--1.02M
-Change in other working capital -32.73%-2.28M56.81%-1.4M-147.24%-8.71M---1.72M---3.24M--18.43M--------
Cash from discontinued investing activities
Operating cash flow -84.20%-53.98M-71.36%-54.6M-1,424.13%-141.22M---29.31M---31.86M136.14%10.67M-301.92%-29.51M---7.34M
Investing cash flow
Cash flow from continuing investing activities -4,080.00%-209K-5,400.00%-385K89.14%-24K-5K-7K-820.83%-221K-50.10%-24K-15.99K
Net PPE purchase and sale -4,080.00%-209K-5,400.00%-385K89.14%-24K---5K---7K-820.83%-221K-50.10%-24K---15.99K
Cash from discontinued investing activities
Investing cash flow -4,080.00%-209K-5,400.00%-385K89.14%-24K---5K---7K-820.83%-221K-50.10%-24K---15.99K
Financing cash flow
Cash flow from continuing financing activities -26.46%4.66M8,185.12%198.18M-97.73%8.91M6.33M2.39M362.68%391.91M508.37%84.7M13.92M
Net issuance payments of debt ----------0----------747K--0--13.92M
Net common stock issuance --0--190.48M--0--0--0368.63%396.95M--84.7M--0
Proceeds from stock option exercised by employees -26.46%4.66M284.74%9.2M--8.91M--6.33M--2.39M--0--0----
Net other financing activities --0---1.5M---------------5.79M--------
Cash from discontinued financing activities
Financing cash flow -26.46%4.66M8,185.12%198.18M-97.73%8.91M--6.33M--2.39M362.68%391.91M508.37%84.7M--13.92M
Net cash flow
Beginning cash position 9.03%481.15M-27.21%340.45M677.85%467.73M--441.31M--467.73M523.38%60.13M213.70%9.65M--3.07M
Current changes in cash -115.57%-49.53M585.76%143.19M-132.89%-132.33M---22.98M---29.48M629.32%402.35M740.43%55.17M--6.56M
Effect of exchange rate changes 44.23%-909K-181.52%-2.5M-3.73%5.05M---1.63M--3.06M212.06%5.25M-15,964.44%-4.68M--29.52K
End cash Position 3.36%430.71M9.03%481.15M-27.21%340.45M--416.71M--441.31M677.85%467.73M521.92%60.13M--9.67M
Free cash flow -84.88%-54.19M-72.54%-54.99M-1,452.37%-141.24M---29.31M---31.87M135.36%10.44M-301.37%-29.54M---7.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion----Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data